The stock of Arvinas Inc (ARVN) has gone down by -9.98% for the week, with a -18.49% drop in the past month and a -6.75% drop in the past quarter. The volatility ratio for the week is 6.93%, and the volatility levels for the past 30 days are 7.09% for ARVN. The simple moving average for the past 20 days is -7.10% for ARVN’s stock, with a -23.40% simple moving average for the past 200 days.
Is It Worth Investing in Arvinas Inc (NASDAQ: ARVN) Right Now?
Company’s 36-month beta value is 1.83.Analysts have differing opinions on the stock, with 15 analysts rating it as a “buy,” 5 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ARVN is 59.52M, and currently, short sellers hold a 15.66% ratio of that floaft. The average trading volume of ARVN on December 11, 2024 was 581.10K shares.
ARVN) stock’s latest price update
The stock price of Arvinas Inc (NASDAQ: ARVN) has plunged by -7.06 when compared to previous closing price of 24.59, but the company has seen a -9.98% decline in its stock price over the last five trading sessions. globenewswire.com reported 2024-12-10 that – Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5%; overall response rate: 26.7%) in patients previously treated with a CDK4/6 inhibitor –
Analysts’ Opinion of ARVN
Many brokerage firms have already submitted their reports for ARVN stocks, with BTIG Research repeating the rating for ARVN by listing it as a “Buy.” The predicted price for ARVN in the upcoming period, according to BTIG Research is $69 based on the research report published on December 10, 2024 of the current year 2024.
Stephens, on the other hand, stated in their research note that they expect to see ARVN reach a price target of $55. The rating they have provided for ARVN stocks is “Overweight” according to the report published on November 18th, 2024.
Oppenheimer gave a rating of “Outperform” to ARVN, setting the target price at $80 in the report published on February 28th of the current year.
ARVN Trading at -11.08% from the 50-Day Moving Average
After a stumble in the market that brought ARVN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.94% of loss for the given period.
Volatility was left at 7.09%, however, over the last 30 days, the volatility rate increased by 6.93%, as shares sank -13.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.44% lower at present.
During the last 5 trading sessions, ARVN fell by -10.28%, which changed the moving average for the period of 200-days by -52.55% in comparison to the 20-day moving average, which settled at $24.60. In addition, Arvinas Inc saw -44.47% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ARVN starting from Loomis David K, who sale 231 shares at the price of $27.69 back on Nov 07 ’24. After this action, Loomis David K now owns 8,040 shares of Arvinas Inc, valued at $6,396 using the latest closing price.
Houston John G, the President and CEO of Arvinas Inc, sale 5,196 shares at $47.05 during a trade that took place back on Feb 23 ’24, which means that Houston John G is holding 1,036,681 shares at $244,472 based on the most recent closing price.
Stock Fundamentals for ARVN
Current profitability levels for the company are sitting at:
- -2.22 for the present operating margin
- 0.97 for the gross margin
The net margin for Arvinas Inc stands at -1.92. The total capital return value is set at -0.4. Equity return is now at value -59.16, with -27.73 for asset returns.
Based on Arvinas Inc (ARVN), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -184.5. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -50.34.
Currently, EBITDA for the company is -394.8 million with net debt to EBITDA at 0.24. When we switch over and look at the enterprise to sales, we see a ratio of 9.19. The receivables turnover for the company is 10.89for trailing twelve months and the total asset turnover is 0.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.17.
Conclusion
In a nutshell, Arvinas Inc (ARVN) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
